Advisory Alpha, LLC Geron Corp Transaction History

Advisory Alpha, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.05 $5,425 - $7,174	-3,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.59 - $2.19 $5,565 - $7,665	3,500 New	3,500 $7,000
Q2 2020 Aug 14, 2020	SELL	$1.05 - $2.18 $3,675 - $7,630	-3,500 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$1.15 - $1.59 $4,024 - $5,565	3,500 New	3,500 $4,000
Q2 2019 Aug 16, 2019	SELL	$1.37 - $2.02 $4,795 - $7,070	-3,500 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$1.01 - $1.83 $3,535 - $6,405	3,500 New	3,500 $0

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.